Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Mainstay Medical

Explore full profile

Innovative implantable neurostimulation system

San Diego, United StatesFounded 2008Biotech & Life Sciences
Valuation $47M Market cap · 2019
Revenue $36M Latest reported FY

At a glance

Status
Listed
Founded
2008
Headquarters
San Diego, United States
Listing
IPO 2014
Employees
210
Open positions
None listed
Dealroom signal
58.4/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, Neurology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
b2b, b2c

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO EQUITY✓Other financing Feb 2024 $125M — Viking Global Investors · Sofinnova Partners · Gilde Healthcare · Perceptive Advisors ↗
POST IPO DEBT✓Debt Apr 2021 $50M — Oxford Finance —
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowthEBITDAMarginProfitMarginR&D
2026 $36M 0% −$18M -50.5% −$22M -60.5% $2.8M
2025 $36M +37.4% −$18M -50.5% −$22M -60.5% $2.8M
2024 $26M +160.3% −$18M -69.4% −$22M -83.1% $2.8M
2023 $10M 0% −$18M -180.5% $2.8M
2022 $10M +90.2% −$18M -180.5%
2021 $5.3M +255.8% −$18M -343.3%
2020 $1.5M — −$18M -1221.6%
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Mainstay Medical website traffic

Latest recorded traffic for Mainstay Medical is 19K monthly website visits, down 47.2% over the last three months. Mainstay Medical's team grew 20% over the past year.

Latest monthly visits19K 3-month web change-47.2% 1-year team growth+20%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

16 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

Series B and later8 investors entered at this stage

  • IPF Partners
  • KCK
  • Capricorn Investment Group
  • Ally Bridge Group
  • Oxford Finance
  • Viking Global Investors
  • Gilde Healthcare
  • Perceptive Advisors

Other known investors4 additional known investors

  • Armentum Partners
  • Ireland Strategic Investment Fund
  • KCK MedTech
  • Quest for Growth
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇺🇸 United States83.7%
🇦🇺 Australia6%
🇩🇪 Germany4.9%
🇬🇧 United Kingdom3.3%
🇮🇪 Ireland1.6%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Mainstay Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mainstay Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.